Results 241 to 250 of about 303,751 (297)

Liver cirrhosis in metabolic dysfunction-associated steatohepatitis. [PDF]

Gastroenterol Rep (Oxf)
Ko D, Kim DH, Danpanichkul P, Nakano M, Rattananukrom C, Wijarnpreecha K, Ng CH, Muthiah MD.   +7 more
europepmc   +1 more source

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

International Journal of Cancer, EarlyView.
What's New? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke, Charline Phan, Yara Souto, Philipp Walter, Mara Goetz, Gediminas Simkus, Jacob Thastrup, Ronald Simon, Jürgen Kupper, Jakob Izbicki, Steven A. Johnsen, Thilo Hackert, Marianne Sinn, Harriet Wikman, Faik G. Uzunoglu, Tabea M. Sturmheit   +15 more
wiley   +1 more source

Clinical Characteristics and Outcomes of Patients with Cirrhosis Who Develop Infective Endocarditis. [PDF]

Infect Dis Rep
Dorff EM, Crooker K, Teng T, Hickey T, HoddWells M, Sarathy A, Muniz S, Lor J, Chang A, Singh D, Dejace J, Riser E, Tompkins BJ, Hale AJ.   +13 more
europepmc   +1 more source

Studies on Cirrhosis of the Liver

, 1959
Takashi Nakamura, Shozo Nakamura, Masamitsu Watanabe, Toshimi Suzuki, Katuhiko Tokita, Toru Kimura, Tadashi Sato, Taketsugu Kaneko   +7 more
openalex   +2 more sources

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of Pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

The Impact of Non-Invasive Scores and Hemogram-Derived Ratios in Differentiating Chronic Liver Disease from Cirrhosis. [PDF]

J Clin Med
Ismaiel A, Katell E, Leucuta DC, Popa SL, Catana CS, Dumitrascu DL, Surdea-Blaga T.   +6 more
europepmc   +1 more source

Antimicrobial Susceptibility Profile of Eggerthella lenta Isolated From Bloodstream and Abdominal Fluid Infections

iLABMED, EarlyView.
Antimicrobial susceptibility analysis of clinical Eggerthella lenta isolates. This study reviewed 36 E. lenta isolates from the bloodstream and abdominal fluids (2018–2024). Identification methods included VITEK 2 ANC, MALDI‐TOF, and 16S rRNA sequencing. Antimicrobial susceptibility testing using agar dilution followed CLSI and EUCAST guidelines.
Yuan Gao, Longfeng Qu, Shu Zhang, Cheng Cheng, Bin Tang   +4 more
wiley   +1 more source

Backtracking to the Brain: A Journey From Cirrhosis to Hypothalamic Insight. [PDF]

Cureus
Haley HN, Ikram FG, Ward AM.
europepmc   +1 more source

Racing toward the future of chronic hepatitis B management: Achieving functional cure and enhancing hepatocellular carcinoma surveillance through precision medicine

Interdisciplinary Medicine, EarlyView.
Novel biomarker emergence plays a critical role in improving CHB management. Advances in sensitive detection methods, AI, and large‐scale data platforms have independently contributed to biomarkers while driving the development of multi‐omics approaches.
Yaru Shi, Rong Fan
wiley   +1 more source